• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

APPLIED DNA SCIENCES, INC.

Notes

No. Proposition For Against Abstain
1

Approval, in accordance with Nasdaq Listing Rules 5635(a) and 5635(d), of the exercisability of certain pre-funded warrants and common stock purchase warrants, and the issuance of the common stock underlying such pre-funded warrants and warrants, which pre-funded warrants and warrants were issued pursuant to a securities purchase agreement dated September 29, 2025.

2

Approval of an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 200,000,000 to 500,000,000.

3

Approval of an amendment to the Companys 2020 Equity Incentive Plan to increase the number of authorized shares of common stock reserved for issuance by 5,000,000 shares.